speb/financial-data huggingface dataset:
Financial ratios for CMX.L — annual report dated 2022-06-30
Total revenue: 30487.80487804878
Operating income: -137632.9268292683
Net income: 29825331.707317077
Capital expenditures: 0
Operating cash flow: -91286.58536585367
Net tangible assets: 43325740.243902445
Owner earnings: 29825331.707317077
Return on net tangible assets (%): 68.83975101040454
Buffett classification: The Gruesome
Stock price: 0.007073170731707317
P/E ratio: 0.004945099966585942
Shares outstanding: 20851928
Book value: 43325740.24390244
P/B ratio: 0.003404194504213361
Market cap (USD): 147489.2468292683
Debt to equity: 1.4073760635787203e-07
Current ratio: 2.8371644247687158
Quick ratio: 2.8371644247687158
Effective tax rate (%): -0.09805255759518501
COGS to revenue (%): 0
SG&A to revenue (%): 551.436
Free cash flow (dilution-adjusted): -91286.58536585367
Buyback yield (%): 0
Retained earnings: 36963553.65853659
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.31767011031886166
FCF margin (%): -299.42
Rule of 40 score: -299.42
Financial ratios for CMX.L — annual report dated 2023-06-30
Total revenue: 31645.56962025316
Operating income: -195502.5316455696
Net income: 3309551.898734177
Capital expenditures: 0
Operating cash flow: -165007.59493670886
Net tangible assets: 46577535.44303797
Owner earnings: 3309551.898734177
Return on net tangible assets (%): 7.105468048608102
Buffett classification: The Gruesome
Stock price: 0.013924050632911394
P/E ratio: 0.08772888600927276
Shares outstanding: 20851928
Book value: 46577535.44303797
P/B ratio: 0.0062335479647886985
Market cap (USD): 290343.30126582284
Debt to equity: 1.3588340095389605e-07
Current ratio: 3.7013004110410606
Quick ratio: 3.7013004110410606
Effective tax rate (%): -1.1724889967905532
COGS to revenue (%): 0
SG&A to revenue (%): 717.788
Free cash flow (dilution-adjusted): -165007.59493670886
Buyback yield (%): 0
Retained earnings: 39973746.835443035
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.41973567254252764
FCF margin (%): -521.424
Revenue growth (%): 3.7974683544303693
Rule of 40 score: -517.6265316455696
Financial ratios for CMX.L — annual report dated 2024-06-30
Total revenue: 31645.56962025316
Operating income: -183470.88607594935
Net income: 358462.0253164557
Capital expenditures: 0
Operating cash flow: -179283.54430379745
Net tangible assets: 39740491.1392405
Owner earnings: 358462.0253164557
Return on net tangible assets (%): 0.9020070337341745
Buffett classification: The Gruesome
Stock price: 0.010253164556962027
P/E ratio: 0.596432073732719
Shares outstanding: 20851928
Book value: 39740491.13924051
P/B ratio: 0.005379859256515722
Market cap (USD): 213798.2491139241
Debt to equity: 1.592610897000502e-07
Current ratio: 10.940553027898282
Quick ratio: 10.940553027898282
Effective tax rate (%): -12.51564455569462
COGS to revenue (%): 0
SG&A to revenue (%): 738.4440000000001
Free cash flow (dilution-adjusted): -179283.54430379745
Buyback yield (%): 0
Retained earnings: 33136702.53164557
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4616724172660935
FCF margin (%): -566.536
Revenue growth (%): 0
Rule of 40 score: -566.536
Financial ratios for CMX.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 38733698.75
Buffett classification: The Gruesome
Stock price: 0.0095
Shares outstanding: 20851928
Market cap (USD): 198093.316
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMX.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 42383568.49315069
Buffett classification: The Gruesome
Stock price: 0.007945205479452055
Shares outstanding: 20851928
Book value: 42383568.49315069
P/B ratio: 0.003908893434244757
Market cap (USD): 165672.85260273973
Debt to equity: 1.6160307666401473e-07
Current ratio: 6.126806633196409
Quick ratio: 6.126806633196409
Buyback yield (%): 0
Retained earnings: 35237002.73972603
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMX.L — annual report dated 2025-06-30
Total revenue: 34246.57534246575
Operating income: -165691.7808219178
Net income: 530301.3698630137
Capital expenditures: 0
Operating cash flow: -160131.50684931508
Net tangible assets: 42383568.49315069
Owner earnings: 530301.3698630137
Return on net tangible assets (%): 1.2511956607634678
Buffett classification: The Gruesome
Stock price: 0.007945205479452055
P/E ratio: 0.3124126431080802
Shares outstanding: 20851928
Book value: 42383568.49315069
P/B ratio: 0.003908893434244757
Market cap (USD): 165672.85260273973
Debt to equity: 1.6160307666401473e-07
Current ratio: 6.126806633196409
Quick ratio: 6.126806633196409
Effective tax rate (%): -7.947130667558976
Interest coverage ratio: -414.22945205479454
COGS to revenue (%): 0
SG&A to revenue (%): 595.8400000000001
Free cash flow (dilution-adjusted): -160131.50684931508
Buyback yield (%): 0
Retained earnings: 35237002.73972603
Receivables turnover: 0.8333333333333333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3909340027579181
FCF margin (%): -467.584
Revenue growth (%): 8.219178082191787
Rule of 40 score: -459.36482191780823
Financial ratios for CTO.AX — annual report dated 2021-06-30
Operating income: -1082695.4887218045
Net income: -1064779.6992481202
Capital expenditures: 3007.518796992481
Depreciation & amortization: 64672.18045112782
Net tangible assets: 76393923.30827068
Owner earnings: -1003115.0375939849
Return on net tangible assets (%): -1.3130822376357572
Buffett classification: The Gruesome
Stock price: 0.007518796992481203
Shares outstanding: 3000000000
Book value: 76810981.95488721
P/B ratio: 0.29366101569553527
Market cap (USD): 22556390.97744361
Debt to equity: 0.006042241805844532
Current ratio: 0.23030728965111552
Quick ratio: 0.23030728965111552
Interest coverage ratio: -11.28329193471294
Free cash flow (dilution-adjusted): -1443739.0977443608
Buyback yield (%): 0
Retained earnings: -118033893.9849624
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3194230729531369
Rule of 40 score: 0
Financial ratios for CTO.AX — annual report dated 2022-06-30
Operating income: -1233834.4827586208
Net income: -1305595.8620689656
Capital expenditures: 139222.06896551725
Depreciation & amortization: 50735.1724137931
Net tangible assets: 69153657.93103449
Owner earnings: -1394082.7586206896
Return on net tangible assets (%): -2.0159204882711763
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3000000000
Book value: 69537925.51724137
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0.016638491848734848
Current ratio: 0.20001537200245953
Quick ratio: 0.20001537200245953
Interest coverage ratio: -8.486237008998241
Free cash flow (dilution-adjusted): -1228845.5172413792
Retained earnings: -109571167.5862069
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6234471996497684
Rule of 40 score: 0
Financial ratios for CTO.AX — annual report dated 2023-06-30
Operating income: -1354839.7350993378
Net income: -1544133.774834437
Capital expenditures: 138872.18543046358
Depreciation & amortization: 38813.24503311258
Net tangible assets: 64994147.01986755
Owner earnings: -1644192.715231788
Return on net tangible assets (%): -2.529755048141778
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 3000000000
Book value: 65440933.77483443
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0.030774781889659156
Current ratio: 0.22916862212787872
Quick ratio: 0.22916862212787872
Interest coverage ratio: -4.924744953227383
Free cash flow (dilution-adjusted): -1377363.5761589403
Retained earnings: -106761480.13245033
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.8348412222796606
Rule of 40 score: 0
Financial ratios for CTRE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.32
Shares outstanding: 236240235
Market cap (USD): 4327921105.2
Buyback yield (%): 0.03075379535918071
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTRE — annual report dated 2022-12-31
Total revenue: 187506000
Gross profit: 178134000
Operating income: 103809000
Net income: -7506000
Capital expenditures: 7292000
Operating cash flow: 144415000
Depreciation & amortization: 50378000
Net tangible assets: 846541000
Owner earnings: 35580000
Capex to operating income (%): 7.02443911414232
Buffett classification: The Great
Stock price: 15.81
Shares outstanding: 236240235
Book value: 849373000
P/B ratio: 4.397312035289561
Market cap (USD): 3734958115.35
Debt to equity: 0.8470930910212592
Current ratio: 0.1463173364987847
Quick ratio: 0.1463173364987847
Interest coverage ratio: 3.459377499333511
COGS to revenue (%): 4.998240056318197
SG&A to revenue (%): 10.275937836655894
Free cash flow (dilution-adjusted): 131365000
Buyback yield (%): 0
Retained earnings: -396954000
Receivables turnover: 450.7355769230769
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.18963120666597
FCF margin (%): 70.05909144240718
Rule of 40 score: 70.05909144240718
Financial ratios for CTRE — annual report dated 2023-12-31
Total revenue: 198599000
Gross profit: 189006000
Operating income: 116002000
Net income: 53735000
Capital expenditures: 10976000
Operating cash flow: 154767000
Depreciation & amortization: 51257000
Net tangible assets: 1411536000
Owner earnings: 94016000
Return on net tangible assets (%): 6.660545675066028
Capex to operating income (%): 9.46190582920984
Buffett classification: The Great
Stock price: 20.13
P/E ratio: 88.49941249744114
Shares outstanding: 236240235
Book value: 1418717000
P/B ratio: 3.3519834685494003
Market cap (USD): 4755515930.55
Debt to equity: 0.41981452255805773
Current ratio: 4.393658806346865
Quick ratio: 4.393658806346865
Effective tax rate (%): 0
Interest coverage ratio: 2.8374140840936333
COGS to revenue (%): 4.994486377071385
SG&A to revenue (%): 10.522208067512928
Free cash flow (dilution-adjusted): 138638000
Buyback yield (%): 0
Retained earnings: -467628000
Receivables turnover: 502.78227848101267
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.758880810598144
FCF margin (%): 69.80800507555426
Revenue growth (%): 5.9160773521913965
Rule of 40 score: 75.72408242774566
Financial ratios for CTRE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.69
Shares outstanding: 236240235
Market cap (USD): 6777732342.150001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTRE — annual report dated 2024-12-31
Total revenue: 228261000
Gross profit: 214709000
Operating income: 124055000
Net income: 125080000
Capital expenditures: 8054000
Operating cash flow: 244251000
Depreciation & amortization: 56932000
Net tangible assets: 2904029000
Owner earnings: 173958000
Return on net tangible assets (%): 5.9902294364140305
Capex to operating income (%): 6.492281649268469
Buffett classification: The Great
Stock price: 25.43
P/E ratio: 48.029974224896065
Shares outstanding: 236240235
Book value: 2929383000
P/B ratio: 2.0508035910804425
Market cap (USD): 6007589176.05
Debt to equity: 0.13549849917200993
Current ratio: 3.326477336368399
Quick ratio: 3.326477336368399
Effective tax rate (%): 0
Interest coverage ratio: 4.092873639063016
COGS to revenue (%): 7.147081630239069
SG&A to revenue (%): 12.224602538322358
Free cash flow (dilution-adjusted): 230067000
Buyback yield (%): 0
Retained earnings: -532570000
Receivables turnover: 2.348895840622363
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7295080735108876
FCF margin (%): 100.79119954788598
Revenue growth (%): 14.935624046445351
Rule of 40 score: 115.72682359433134
Financial ratios for CTRE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.43
Shares outstanding: 236240235
Market cap (USD): 6007589176.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTRE — quarterly report dated 2025-03-31
Total revenue: 71646000
Gross profit: 69476000
Operating income: 42612000
Net income: 65802000
Capital expenditures: 2276000
Operating cash flow: 71382000
Depreciation & amortization: 17865000
Net tangible assets: 2923229000
Owner earnings: 81391000
Return on net tangible assets (%): 2.784284091325038
Capex to operating income (%): 5.34121843612128
Buffett classification: The Great
Stock price: 27.18
P/E ratio: 24.395191587261785
Shares outstanding: 236240235
Book value: 2948177000
P/B ratio: 2.1779593244571136
Market cap (USD): 6421009587.3
Debt to equity: 0.27886690656632895
Current ratio: 6.55288200346997
Quick ratio: 6.55288200346997
Effective tax rate (%): 0
Interest coverage ratio: 6.389563652721548
COGS to revenue (%): 4.219356279485247
SG&A to revenue (%): 12.289590486558915
Free cash flow (dilution-adjusted): 65197000
Buyback yield (%): 0
Retained earnings: -529821000
Receivables turnover: 0.7267655352904181
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.130194046880827
FCF margin (%): 90.99879965385367
Rule of 40 score: 90.99879965385367
Financial ratios for CTRE — quarterly report dated 2025-06-30
Total revenue: 86033000
Gross profit: 82978000
Operating income: 49214000
Net income: 68545000
Capital expenditures: 4507000
Operating cash flow: 100775000
Depreciation & amortization: 21257000
Net tangible assets: 3261264000
Owner earnings: 85295000
Return on net tangible assets (%): 2.6153969749152477
Capex to operating income (%): 9.157963181208599
Buffett classification: The Great
Stock price: 29.42
P/E ratio: 51.73310690748584
Shares outstanding: 236240235
Book value: 3324977000
P/B ratio: 2.0902964783515796
Market cap (USD): 6950187713.700001
Debt to equity: 0.3474851104233202
Current ratio: 2.6180594185294086
Quick ratio: 2.6180594185294086
Effective tax rate (%): 1.4942261939302501
Interest coverage ratio: 3.7746586899831263
COGS to revenue (%): 4.577313356502737
SG&A to revenue (%): 14.039961410156568
Free cash flow (dilution-adjusted): 93242000
Buyback yield (%): 0
Retained earnings: -528376000
Receivables turnover: 0.8601837687593109
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0984392538362455
FCF margin (%): 108.37934281031698
Revenue growth (%): 20.08067442704408
Rule of 40 score: 128.46001723736106
Financial ratios for CTRE — quarterly report dated 2025-09-30
Total revenue: 104265000
Gross profit: 101660000
Operating income: 59547000
Net income: 74930000
Capital expenditures: 3230000
Operating cash flow: 100912000
Depreciation & amortization: 26737000
Net tangible assets: 3947120000
Owner earnings: 98437000
Return on net tangible assets (%): 2.4938942824135064
Capex to operating income (%): 5.424286697902497
Buffett classification: The Great
Stock price: 33.67
P/E ratio: 38.00804059906249
Shares outstanding: 236240235
Book value: 4017210000
P/B ratio: 1.9800330857610131
Market cap (USD): 7954208712.450001
Debt to equity: 0.2224914804055551
Current ratio: 4.755450636539921
Quick ratio: 4.755450636539921
Effective tax rate (%): 2.6971574012752084
Interest coverage ratio: 4.717715100617968
COGS to revenue (%): 7.032081714861171
SG&A to revenue (%): 14.287632474943655
Free cash flow (dilution-adjusted): 95189000
Buyback yield (%): 0
Retained earnings: -528281000
Receivables turnover: 0.9888280872129966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2125216732623976
FCF margin (%): 91.29525727713039
Revenue growth (%): 21.191868236606883
Rule of 40 score: 112.48712551373727
Financial ratios for CTRE — annual report dated 2025-12-31
Total revenue: 369419000
Gross profit: 359837000
Operating income: 214481000
Net income: 320538000
Capital expenditures: 14992000
Operating cash flow: 394029000
Depreciation & amortization: 93045000
Net tangible assets: 3986948000
Owner earnings: 398591000
Return on net tangible assets (%): 9.997396504795146
Capex to operating income (%): 6.989896540952345
Buffett classification: The Great
Stock price: 35.43
P/E ratio: 26.11232217724576
Shares outstanding: 236240235
Book value: 4058968000
P/B ratio: 2.0620984265089057
Market cap (USD): 8369991526.05
Debt to equity: 0.22030723080349487
Current ratio: 1.5395957961157092
Quick ratio: 1.5395957961157092
Effective tax rate (%): 1.5374115780833542
Interest coverage ratio: 4.907245978904981
COGS to revenue (%): 4.340058307775182
SG&A to revenue (%): 13.678505978306477
Free cash flow (dilution-adjusted): 367141000
Buyback yield (%): 0
Retained earnings: -491796000
Receivables turnover: 3.6019442088123164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.330160696504958
FCF margin (%): 99.38335602662559
Revenue growth (%): 61.84061228155488
Rule of 40 score: 161.22396830818047
Financial ratios for CTRE — quarterly report dated 2025-12-31
Total revenue: 107475000
Gross profit: 105723000
Operating income: 63108000
Net income: 112261000
Capital expenditures: 4979000
Operating cash flow: 120960000
Depreciation & amortization: 27186000
Net tangible assets: 3986948000
Owner earnings: 134468000
Return on net tangible assets (%): 3.3727051368615792
Capex to operating income (%): 7.889649489763579
Buffett classification: The Great
Stock price: 35.43
P/E ratio: 26.03111148931075
Shares outstanding: 236240235
Book value: 4058968000
P/B ratio: 2.0620984265089057
Market cap (USD): 8369991526.05
Debt to equity: 0.22030723080349487
Current ratio: 1.5395957961157092
Quick ratio: 1.5395957961157092
Effective tax rate (%): 1.6591476501248303
Interest coverage ratio: 5.5464932325540515
COGS to revenue (%): 1.6301465457083042
SG&A to revenue (%): 13.725052337752967
Free cash flow (dilution-adjusted): 113513000
Buyback yield (%): 0
Retained earnings: -491796000
Receivables turnover: 1.0479129493667183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2740885264197523
FCF margin (%): 105.61805070946733
Revenue growth (%): 3.078693713134801
Rule of 40 score: 108.69674442260212
Financial ratios for DBSTOCKBRO.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3375972570222867
Shares outstanding: 35000000
Market cap (USD): 11815903.995780034
Buyback yield (%): 0
Retained earnings: 4356150.969273374
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBSTOCKBRO.NS — annual report dated 2023-03-31
Total revenue: 1141079.293544458
Gross profit: 668342.1071863582
Operating income: -1288500.7917174178
Net income: 776493.0694275275
Capital expenditures: 321970.8769792936
Operating cash flow: 473600.4628501827
Depreciation & amortization: 136322.7161997564
Net tangible assets: 6766209.049939099
Owner earnings: 590844.9086479903
Return on net tangible assets (%): 8.73228870534688
Buffett classification: The Gruesome
Stock price: 0.2746650426309379
P/E ratio: 12.380376426502108
Shares outstanding: 35000000
Book value: 6967297.24725944
P/B ratio: 1.3797712586274644
Market cap (USD): 9613276.492082827
Debt to equity: 0.11461078307470705
Current ratio: 2.115708077165847
Quick ratio: 2.115708077165847
Effective tax rate (%): 26.724724826112528
Interest coverage ratio: -46.16218743645308
COGS to revenue (%): 41.42895143506357
SG&A to revenue (%): 3.7270524380138426
Free cash flow (dilution-adjusted): 151629.58587088916
Buyback yield (%): 0
Retained earnings: 4779830.328867235
Receivables turnover: 5.519311632343961
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.964745412932096
FCF margin (%): 13.288260222468182
Rule of 40 score: 13.288260222468182
Financial ratios for DBSTOCKBRO.NS — annual report dated 2024-03-31
Total revenue: 1564799.7241875525
Gross profit: -960904.2091377863
Operating income: -2539556.745413119
Net income: 1084992.936802974
Capital expenditures: 42656.01391054083
Operating cash flow: -847598.4770356158
Depreciation & amortization: 244862.18971099652
Net tangible assets: 7877394.4357836675
Owner earnings: 1287199.1126034297
Return on net tangible assets (%): 16.340417165810933
Buffett classification: The Gruesome
Stock price: 0.47384836852207296
P/E ratio: 15.285530749297589
Shares outstanding: 35000000
Book value: 7950329.9676220175
P/B ratio: 2.086038311090768
Market cap (USD): 16584692.898272553
Debt to equity: 0.06065427364034948
Current ratio: 0.1812770148490699
Quick ratio: 0.1812770148490699
Effective tax rate (%): 22.591606209121334
Interest coverage ratio: -12.729334586469328
COGS to revenue (%): 161.40748840153904
SG&A to revenue (%): 8.070654482751216
Free cash flow (dilution-adjusted): -890254.4909461566
Buyback yield (%): 0
Retained earnings: 5793469.888475836
Receivables turnover: 7.131336265250637
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.42684039216292
FCF margin (%): -56.892551627230034
Revenue growth (%): 37.13330292121243
Rule of 40 score: -19.7592487060176
Financial ratios for DBSTOCKBRO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 8281665.074056379
Buffett classification: The Gruesome
Stock price: 0.5641423793597706
Shares outstanding: 35000000
Book value: 8333647.873865265
P/B ratio: 2.36930856408191
Market cap (USD): 19744983.277591974
Debt to equity: 0.06524072908858194
Current ratio: 1.5226085275311512
Quick ratio: 1.5226085275311512
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBSTOCKBRO.NS — quarterly report dated 2024-12-31
Total revenue: 397610.44410770485
Gross profit: 182935.0740179508
Operating income: -516994.98776081123
Net income: 120491.8988227066
Capital expenditures: 0
Depreciation & amortization: 36577.6897074251
Owner earnings: 157069.5885301317
Buffett classification: The Gruesome
Stock price: 0.5543769670124723
P/E ratio: 40.25829544355229
Shares outstanding: 35000000
Market cap (USD): 19403193.845436532
Effective tax rate (%): -9.571761712953148
Interest coverage ratio: -12.258982863460476
COGS to revenue (%): 53.99138107941719
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBSTOCKBRO.NS — annual report dated 2025-03-31
Total revenue: 1827577.7414075285
Gross profit: 950444.2366144493
Operating income: -2031201.7769464576
Net income: 676572.3638064063
Capital expenditures: 82873.50946925415
Operating cash flow: 18704.699555763385
Depreciation & amortization: 173182.13701192423
Net tangible assets: 8392288.753799392
Owner earnings: 766880.9913490764
Return on net tangible assets (%): 9.137924276043181
Buffett classification: The Gruesome
Stock price: 0.32956004201190336
P/E ratio: 17.048585025735868
Shares outstanding: 35000000
Book value: 8419793.850830019
P/B ratio: 1.3699387033424273
Market cap (USD): 11534601.470416619
Debt to equity: 0.040635750927087565
Current ratio: 2.83471275583851
Quick ratio: 2.83471275583851
Effective tax rate (%): 18.54010077977648
Interest coverage ratio: -8.74957196092255
COGS to revenue (%): 47.99431974464438
SG&A to revenue (%): 3.2142332614772497
Free cash flow (dilution-adjusted): -64168.80991349076
Buyback yield (%): 0
Retained earnings: 6302149.544072947
Receivables turnover: 4.22010567716255
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.117802885099515
FCF margin (%): -3.5111398251146606
Revenue growth (%): 16.79307665755188
Rule of 40 score: 13.281936832437218
Financial ratios for DBSTOCKBRO.NS — quarterly report dated 2025-03-31
Total revenue: 271031.0965630114
Gross profit: 57400.04676174888
Operating income: -412917.93313069904
Net income: 157002.5718961889
Capital expenditures: 0
Depreciation & amortization: 54442.3661444938
Net tangible assets: 8392288.753799392
Owner earnings: 211444.9380406827
Return on net tangible assets (%): 2.5195145715756797
Buffett classification: The Gruesome
Stock price: 0.32956004201190336
P/E ratio: 18.366898916221846
Shares outstanding: 35000000
Book value: 8419793.850830019
P/B ratio: 1.3699387033424273
Market cap (USD): 11534601.470416619
Debt to equity: 0.040635750927087565
Current ratio: 2.83471275583851
Quick ratio: 2.83471275583851
Effective tax rate (%): 24.54632282712512
Interest coverage ratio: -19.3327859879584
COGS to revenue (%): 78.82160110420982
Buyback yield (%): 0
Retained earnings: 6302149.544072947
Receivables turnover: 0.6258447142239002
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.699560375625759
Revenue growth (%): -31.835015759899303
Rule of 40 score: -31.835015759899303
Financial ratios for DBSTOCKBRO.NS — quarterly report dated 2025-06-30
Total revenue: 277182.30751228647
Gross profit: 74432.4830329979
Operating income: -348408.61221624154
Net income: 118008.42499414932
Capital expenditures: 0
Depreciation & amortization: 34577.58015445823
Owner earnings: 152586.00514860754
Buffett classification: The Gruesome
Stock price: 0.37608237772057107
P/E ratio: 33.28138267227822
Shares outstanding: 35000000
Market cap (USD): 13162883.220219988
Effective tax rate (%): 23.66209976534706
Interest coverage ratio: -10.238995873452545
COGS to revenue (%): 73.1467409658899
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.2695591123231056
Rule of 40 score: 2.2695591123231056
Financial ratios for DBSTOCKBRO.NS — quarterly report dated 2025-12-31
Total revenue: 328639.8574133898
Gross profit: 138442.68686643644
Operating income: -240492.36938843713
Net income: 99287.06694886934
Capital expenditures: 0
Depreciation & amortization: 33574.690876684865
Owner earnings: 132861.7578255542
Buffett classification: The Gruesome
Stock price: 0.2784894730979169
P/E ratio: 19.699533729400297
Shares outstanding: 35000000
Market cap (USD): 9747131.558427092
Effective tax rate (%): 22.951244813278006
Interest coverage ratio: -6.338520258367587
COGS to revenue (%): 57.87404243780083
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 18.564514583537186
Rule of 40 score: 18.564514583537186
Financial ratios for DKNG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.47
Shares outstanding: 496128817
Market cap (USD): 13628658602.99
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DKNG — annual report dated 2022-12-31
Total revenue: 2240461000
Gross profit: 756188000
Operating income: -1511756000
Net income: -1377987000
Capital expenditures: 32402000
Operating cash flow: -625519000
Depreciation & amortization: 169252000
Net tangible assets: -340614000
Owner earnings: -1241137000
Buffett classification: The Gruesome
Stock price: 11.39
Shares outstanding: 496128817
Book value: 1322693000
P/B ratio: 4.272274235691881
Market cap (USD): 5650907225.63
Debt to equity: 1.0015082865033684
Current ratio: 1.672613656146983
Quick ratio: 1.672613656146983
Interest coverage ratio: -570.2587702753677
COGS to revenue (%): 66.24855331112659
R&D to revenue (%): 14.204532013723961
SG&A to revenue (%): 87.02213517664444
Free cash flow (dilution-adjusted): -1307963000
Buyback yield (%): 0.4515912044044393
Retained earnings: -5131801000
Receivables turnover: 10.609248034851785
Capitalized R&D asset: 318247000
ROCI (R&D-adjusted, %): -41.761425287917746
FCF margin (%): -58.37919071119738
Rule of 40 score: -58.37919071119738
Financial ratios for DKNG — annual report dated 2023-12-31
Total revenue: 3665393000
Gross profit: 1373218000
Operating income: -789225000
Net income: -802142000
Capital expenditures: 20902000
Operating cash flow: -1751000
Depreciation & amortization: 201920000
Net tangible assets: -736687000
Owner earnings: -621124000
Buffett classification: The Gruesome
Stock price: 35.25
Shares outstanding: 496128817
Book value: 840306000
P/B ratio: 20.812109873367557
Market cap (USD): 17488540799.25
Debt to equity: 1.6018997841262588
Current ratio: 1.3366935119577703
Quick ratio: 1.3366935119577703
Interest coverage ratio: -294.5968645016797
COGS to revenue (%): 62.535586224996884
R&D to revenue (%): 9.689438485859498
SG&A to revenue (%): 49.306772834454584
Free cash flow (dilution-adjusted): -513599000
Buyback yield (%): 0.45772257913840886
Retained earnings: -5933943000
Receivables turnover: 10.493268137952358
Capitalized R&D asset: 568381490
ROCI (R&D-adjusted, %): -22.22062890456812
Rosenberg metric: 1.938839957642963
FCF margin (%): -14.012112752984468
Revenue growth (%): 63.59994661812903
Rule of 40 score: 49.58783386514456
Financial ratios for DKNG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.2
Shares outstanding: 496128817
Market cap (USD): 19448249626.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DKNG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.2
Shares outstanding: 496128817
Market cap (USD): 18455991992.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DKNG — annual report dated 2024-12-31
Total revenue: 4767699000
Gross profit: 1817138000
Operating income: -608999000
Net income: -507285000
Capital expenditures: 10176000
Operating cash flow: 417767000
Depreciation & amortization: 270854000
Net tangible assets: -1477611000
Owner earnings: -246607000
Buffett classification: The Gruesome
Stock price: 37.2
Shares outstanding: 496128817
Book value: 1010626000
P/B ratio: 18.2619406114626
Market cap (USD): 18455991992.4
Debt to equity: 1.32104458028984
Current ratio: 0.9267488463683489
Quick ratio: 0.9267488463683489
Interest coverage ratio: -205.81243663399798
COGS to revenue (%): 61.886478152249126
R&D to revenue (%): 8.329259040891634
SG&A to revenue (%): 42.55769921716954
Free cash flow (dilution-adjusted): -84457000
Buyback yield (%): 0.8179674116794454
Retained earnings: -6441228000
Receivables turnover: 82.43052265772229
Capitalized R&D asset: 740090030
ROCI (R&D-adjusted, %): -16.881974093493984
Rosenberg metric: 1.2499296083974367
FCF margin (%): -1.7714415276635542
Revenue growth (%): 30.073337292890557
Rule of 40 score: 28.301895765227002
Financial ratios for DKNG — quarterly report dated 2025-03-31
Total revenue: 1408806000
Gross profit: 565003000
Operating income: -46331000
Net income: -33864000
Capital expenditures: 2647000
Operating cash flow: -119016000
Depreciation & amortization: 70116000
Net tangible assets: -1586726000
Owner earnings: 33605000
Buffett classification: The Gruesome
Stock price: 33.21
Shares outstanding: 496128817
Book value: 872915000
P/B ratio: 18.87519175700956
Market cap (USD): 16476438012.57
Debt to equity: 2.198317132825075
Current ratio: 1.2014366794251414
Quick ratio: 1.2014366794251414
Interest coverage ratio: -9.09521005104044
COGS to revenue (%): 59.894903911539274
R&D to revenue (%): 7.3296110323209875
SG&A to revenue (%): 36.06415645589244
Free cash flow (dilution-adjusted): -233386000
Buyback yield (%): 1.3145802498984143
Retained earnings: -6475092000
Receivables turnover: 9.549479078405987
Capitalized R&D asset: 103260000
ROCI (R&D-adjusted, %): 0.721396064354849
FCF margin (%): -16.566227003576078
Rule of 40 score: -16.566227003576078
Financial ratios for DKNG — quarterly report dated 2025-06-30
Total revenue: 1512507000
Gross profit: 657948000
Operating income: 150644000
Net income: 157936000
Capital expenditures: 4316000
Operating cash flow: 173921000
Depreciation & amortization: 65299000
Net tangible assets: -1425484000
Owner earnings: 218919000
Return on net tangible assets (%): -15.357520673679955
Capex to operating income (%): 2.865032792544011
Buffett classification: The Great
Stock price: 42.89
P/E ratio: 171.50497260566445
Shares outstanding: 496128817
Book value: 1009628000
P/B ratio: 21.07604480177848
Market cap (USD): 21278964961.13
Debt to equity: 1.8917294290570388
Current ratio: 1.3387995830813764
Quick ratio: 1.3387995830813764
Effective tax rate (%): 6.938681827009657
Interest coverage ratio: 12.94192439862543
COGS to revenue (%): 56.49950710971916
R&D to revenue (%): 7.168032941335148
SG&A to revenue (%): 26.372572159996615
Free cash flow (dilution-adjusted): 55133000
Buyback yield (%): 0.6015189189596881
Retained earnings: -6317156000
Receivables turnover: 11.07471462148448
Capitalized R&D asset: 177601200
ROCI (R&D-adjusted, %): 5.682306317855739
Rosenberg metric: 0.9001065272128608
FCF margin (%): 3.645140154723251
Revenue growth (%): 7.360914135800104
Rule of 40 score: 11.006054290523355
Financial ratios for DKNG — quarterly report dated 2025-09-30
Total revenue: 1144019000
Gross profit: 359940000
Operating income: -271890000
Net income: -256788000
Capital expenditures: 4433000
Operating cash flow: 287477000
Depreciation & amortization: 66071000
Net tangible assets: -1683871000
Owner earnings: -195150000
Buffett classification: The Gruesome
Stock price: 37.4
Shares outstanding: 496128817
Book value: 732286000
P/B ratio: 25.338758020500187
Market cap (USD): 18555217755.8
Debt to equity: 2.603615254149335
Current ratio: 1.0949692962801998
Quick ratio: 1.0949692962801998
COGS to revenue (%): 68.53723583262166
R&D to revenue (%): 10.024309036825438
SG&A to revenue (%): 45.20466880357756
Free cash flow (dilution-adjusted): 175444000
Buyback yield (%): 0.5542376346828601
Retained earnings: -6573944000
Receivables turnover: 9.417964633825079
Capitalized R&D asset: 221395190
ROCI (R&D-adjusted, %): -8.666335109873007
Rosenberg metric: -2.7487202191538227
FCF margin (%): 15.33575928371819
Revenue growth (%): -24.362730222075005
Rule of 40 score: -9.026970938356815
Financial ratios for DKNG — annual report dated 2025-12-31
Total revenue: 6054525000
Gross profit: 2497578000
Operating income: -15817000
Net income: 3710000
Capital expenditures: 15352000
Operating cash flow: 662855000
Depreciation & amortization: 275488000
Net tangible assets: -1855387000
Owner earnings: 263846000
Return on net tangible assets (%): -14.22053727874562
Buffett classification: The Gruesome
Stock price: 34.46
P/E ratio: 4608.247718010782
Shares outstanding: 496128817
Book value: 631461000
P/B ratio: 27.07467133175287
Market cap (USD): 17096599033.82
Debt to equity: 2.9927834023003794
Current ratio: 1.0339156841668133
Quick ratio: 1.0339156841668133
Effective tax rate (%): 60.94396121488664
COGS to revenue (%): 58.748572348780456
R&D to revenue (%): 7.596169806879978
SG&A to revenue (%): 33.91650046865774
Free cash flow (dilution-adjusted): 169082000
Buyback yield (%): 4.850596299062336
Retained earnings: -6437518000
Receivables turnover: 57.34700739744452
Capitalized R&D asset: 843179860
ROCI (R&D-adjusted, %): 1.1063814378601071
Rosenberg metric: 1.7134626328963471
FCF margin (%): 2.792655080291187
Revenue growth (%): 26.990504224364837
Rule of 40 score: 29.783159304656024
Financial ratios for DKNG — quarterly report dated 2025-12-31
Total revenue: 1989193000
Gross profit: 914687000
Operating income: 151760000
Net income: 136426000
Capital expenditures: 3956000
Operating cash flow: 320473000
Depreciation & amortization: 74002000
Net tangible assets: -1855387000
Owner earnings: 206472000
Return on net tangible assets (%): -11.128244403997657
Capex to operating income (%): 2.606747496046389
Buffett classification: The Great
Stock price: 34.46
P/E ratio: 4608.247718010782
Shares outstanding: 496128817
Book value: 631461000
P/B ratio: 27.07467133175287
Market cap (USD): 17096599033.82
Debt to equity: 2.9927834023003794
Current ratio: 1.0339156841668133
Quick ratio: 1.0339156841668133
Effective tax rate (%): 6.902907668763817
COGS to revenue (%): 54.017181842083694
R&D to revenue (%): 6.714029257090689
SG&A to revenue (%): 31.639564386160618
Free cash flow (dilution-adjusted): 171891000
Buyback yield (%): 2.2335085431004575
Retained earnings: -6437518000
Receivables turnover: 18.841158585676805
Capitalized R&D asset: 246168210
ROCI (R&D-adjusted, %): 5.50825864642726
Rosenberg metric: 4.837347401464946
FCF margin (%): 8.641242956314445
Revenue growth (%): 73.87761916541596
Rule of 40 score: 82.51886212173041
Financial ratios for ECL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 222.87
Shares outstanding: 281437502
Market cap (USD): 62723976070.74
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECL — annual report dated 2022-12-31
Total revenue: 14187800000
Gross profit: 5356800000
Operating income: 1703000000
Net income: 1108900000
Capital expenditures: 2200000
Operating cash flow: 1788400000
Depreciation & amortization: 938700000
Net tangible assets: -4457300000
Owner earnings: 2045400000
Return on net tangible assets (%): -45.888766742198186
Capex to operating income (%): 0.1291837933059307
Buffett classification: The Great
Stock price: 140.19
P/E ratio: 35.58005537503833
Shares outstanding: 281437502
Book value: 7258600000
P/B ratio: 5.435583088388945
Market cap (USD): 39454723405.38
Debt to equity: 1.2435593640646956
Current ratio: 1.3049116473494204
Quick ratio: 0.879108873266198
Effective tax rate (%): 17.455709394074738
Interest coverage ratio: 6.755255850852836
COGS to revenue (%): 62.24361775610031
SG&A to revenue (%): 25.753111828472345
Free cash flow (dilution-adjusted): 987800000
Buyback yield (%): 1.3134042144351692
Retained earnings: 9318800000
Inventory turnover: 4.925814368585453
Receivables turnover: 4.9225591562001245
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.870232237349237
FCF margin (%): 6.962319739494495
Rule of 40 score: 6.962319739494495
Financial ratios for ECL — annual report dated 2023-12-31
Total revenue: 15320200000
Gross profit: 6165300000
Operating income: 2103700000
Net income: 1393000000
Capital expenditures: 9900000
Operating cash flow: 2411800000
Depreciation & amortization: 923600000
Net tangible assets: -3597000000
Owner earnings: 2306700000
Return on net tangible assets (%): -64.12844036697247
Capex to operating income (%): 0.4705994200694015
Buffett classification: The Great
Stock price: 193.38
P/E ratio: 39.06990964591529
Shares outstanding: 281437502
Book value: 8072200000
P/B ratio: 6.742199665117315
Market cap (USD): 54424384136.76
Debt to equity: 1.0819107554322243
Current ratio: 1.2987482166689677
Quick ratio: 0.9542316719591329
Effective tax rate (%): 20.64938763884933
Interest coverage ratio: 6.029521352823158
COGS to revenue (%): 59.75705277998982
SG&A to revenue (%): 26.511403245388443
Free cash flow (dilution-adjusted): 1541900000
Buyback yield (%): 0.02517254024514827
Retained earnings: 10075400000
Inventory turnover: 6.114680737376436
Receivables turnover: 5.0710668299625965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.02059334430426
FCF margin (%): 10.064490019712537
Revenue growth (%): 7.981505236893669
Rule of 40 score: 18.045995256606204
Financial ratios for ECL — annual report dated 2024-12-31
Total revenue: 15741400000
Gross profit: 6841700000
Operating income: 2613500000
Net income: 2131900000
Capital expenditures: 11300000
Operating cash flow: 2813900000
Depreciation & amortization: 935400000
Net tangible assets: -2458800000
Owner earnings: 3056000000
Return on net tangible assets (%): -124.28827070115504
Capex to operating income (%): 0.4323703845418022
Buffett classification: The Great
Stock price: 230.69
P/E ratio: 30.453969387110092
Shares outstanding: 281437502
Book value: 8789200000
P/B ratio: 7.386885875435762
Market cap (USD): 64924817336.38
Debt to equity: 0.9423724571064488
Current ratio: 1.2572400267067267
Quick ratio: 0.9515940577532966
Effective tax rate (%): 17.085407591785938
Interest coverage ratio: 7.679988245665589
COGS to revenue (%): 56.536902689722645
SG&A to revenue (%): 26.860380906399683
Free cash flow (dilution-adjusted): 1684600000
Buyback yield (%): 1.5194497889595513
Retained earnings: 11517100000
Inventory turnover: 6.075295241996041
Receivables turnover: 5.1980979427401515
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.853651605569764
FCF margin (%): 10.701716492815125
Revenue growth (%): 2.749311366692341
Rule of 40 score: 13.451027859507466
Financial ratios for ECL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 230.69
Shares outstanding: 281437502
Market cap (USD): 64924817336.38
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECL — quarterly report dated 2025-03-31
Total revenue: 3695000000
Gross profit: 1634800000
Operating income: 584800000
Net income: 406500000
Capital expenditures: 21600000
Operating cash flow: 369400000
Depreciation & amortization: 236100000
Net tangible assets: -2217400000
Owner earnings: 621000000
Return on net tangible assets (%): -28.00577252638225
Capex to operating income (%): 3.6935704514363885
Buffett classification: The Great
Stock price: 250.23
P/E ratio: 43.311258379741695
Shares outstanding: 281437502
Book value: 8903700000
P/B ratio: 7.909532680285723
Market cap (USD): 70424106125.45999
Debt to equity: 0.9386996417219807
Current ratio: 1.3193395817061528
Quick ratio: 0.9836631085654778
Effective tax rate (%): 20.294117647058822
Interest coverage ratio: 8.055096418732782
COGS to revenue (%): 55.75642760487145
SG&A to revenue (%): 28.416779431664413
Free cash flow (dilution-adjusted): 89300000
Buyback yield (%): 0.21824913152065384
Retained earnings: 11735200000
Inventory turnover: 1.3315667011375387
Receivables turnover: 1.2225788306918572
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2933120086500125
FCF margin (%): 2.4167794316644113
Rule of 40 score: 2.4167794316644113
Financial ratios for ECL — quarterly report dated 2025-06-30
Total revenue: 4025200000
Gross profit: 1802400000
Operating income: 734700000
Net income: 528500000
Capital expenditures: 20800000
Operating cash flow: 701800000
Depreciation & amortization: 241700000
Net tangible assets: -1924000000
Owner earnings: 749400000
Return on net tangible assets (%): -38.95010395010395
Capex to operating income (%): 2.8310875187151217
Buffett classification: The Great
Stock price: 266.6
P/E ratio: 35.492544008136235
Shares outstanding: 281437502
Book value: 9350600000
P/B ratio: 8.024216417470537
Market cap (USD): 75031238033.20001
Debt to equity: 0.9590186725985498
Current ratio: 1.4415401853926861
Quick ratio: 1.1218091066517266
Effective tax rate (%): 19.912107895135627
Interest coverage ratio: 9.641732283464567
COGS to revenue (%): 55.22210076517937
SG&A to revenue (%): 26.525390042730795
Free cash flow (dilution-adjusted): 451400000
Buyback yield (%): 0.06064140908866124
Retained earnings: 12075100000
Inventory turnover: 1.4163374538040014
Receivables turnover: 1.2428827271043044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9022706147921924
FCF margin (%): 11.214349597535527
Revenue growth (%): 8.93640054127199
Rule of 40 score: 20.150750138807517
Financial ratios for ECL — quarterly report dated 2025-09-30
Total revenue: 4165000000
Gross profit: 1865600000
Operating income: 786400000
Net income: 589700000
Capital expenditures: 4000000
Operating cash flow: 791300000
Depreciation & amortization: 242500000
Net tangible assets: -1529500000
Owner earnings: 828200000
Return on net tangible assets (%): -54.14841451454724
Capex to operating income (%): 0.508646998982706
Buffett classification: The Great
Stock price: 271.62
P/E ratio: 50.137111755256775
Shares outstanding: 281437502
Book value: 9753900000
P/B ratio: 7.83728091258266
Market cap (USD): 76444054293.24
Debt to equity: 0.9052789140753955
Current ratio: 1.6968387374050904
Quick ratio: 1.3303567164891839
Effective tax rate (%): 17.834749895499513
Interest coverage ratio: 10.541554959785524
COGS to revenue (%): 55.2076830732293
SG&A to revenue (%): 25.911164465786314
Free cash flow (dilution-adjusted): 496100000
Buyback yield (%): 0.22944884546175978
Retained earnings: 12475900000
Inventory turnover: 1.4980780506873412
Receivables turnover: 1.2548960530280204
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.989974326970887
FCF margin (%): 11.911164465786314
Revenue growth (%): 3.473119348106926
Rule of 40 score: 15.38428381389324
Financial ratios for ECL — annual report dated 2025-12-31
Total revenue: 16081200000
Gross profit: 7150400000
Operating income: 2892500000
Net income: 2093300000
Capital expenditures: 52300000
Operating cash flow: 2952600000
Depreciation & amortization: 976400000
Net tangible assets: -3144700000
Owner earnings: 3017400000
Return on net tangible assets (%): -95.9519191019811
Capex to operating income (%): 1.8081244598098531
Buffett classification: The Great
Stock price: 261.11
P/E ratio: 35.10540588889314
Shares outstanding: 281437502
Book value: 9804500000
P/B ratio: 7.495144693479524
Market cap (USD): 73486146147.22
Debt to equity: 0.9176908562394819
Current ratio: 1.0760474822483603
Quick ratio: 0.8067645942869532
Effective tax rate (%): 17.842144511166058
Interest coverage ratio: 9.44644023514043
COGS to revenue (%): 55.535656543044055
SG&A to revenue (%): 26.47750167897918
Free cash flow (dilution-adjusted): 1767700000
Buyback yield (%): 1.0665955980733537
Retained earnings: 12834000000
Inventory turnover: 5.9922168545356955
Receivables turnover: 4.47122282155369
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.095294756179026
FCF margin (%): 10.992338880183071
Revenue growth (%): 2.1586390028841147
Rule of 40 score: 13.150977883067187
Financial ratios for ECL — quarterly report dated 2025-12-31
Total revenue: 4196000000
Gross profit: 1847600000
Operating income: 786600000
Net income: 568600000
Capital expenditures: 5900000
Operating cash flow: 1090100000
Depreciation & amortization: 256100000
Net tangible assets: -3144700000
Owner earnings: 818800000
Return on net tangible assets (%): -26.03745985308614
Capex to operating income (%): 0.7500635647088736
Buffett classification: The Great
Stock price: 261.11
P/E ratio: 35.10540588889314
Shares outstanding: 281437502
Book value: 9804500000
P/B ratio: 7.495144693479524
Market cap (USD): 73486146147.22
Debt to equity: 0.9176908562394819
Current ratio: 1.0760474822483603
Quick ratio: 0.8067645942869532
Effective tax rate (%): 13.887626836286538
Interest coverage ratio: 9.48854041013269
COGS to revenue (%): 55.96758817921831
SG&A to revenue (%): 25.28598665395615
Free cash flow (dilution-adjusted): 730900000
Buyback yield (%): 0.556839651354448
Retained earnings: 12834000000
Inventory turnover: 1.575684380032206
Receivables turnover: 1.1666573986542845
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.105085170340681
FCF margin (%): 17.41897044804576
Revenue growth (%): 0.744297719087635
Rule of 40 score: 18.163268167133392
Financial ratios for ECU.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.45669291338582674
Shares outstanding: 188697567
Market cap (USD): 86176841.62204723
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECU.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -13060.294117647058
Operating income: -2875018.3823529407
Net income: -3854365.4411764704
Capital expenditures: 3857069.1176470583
Operating cash flow: -1637857.3529411764
Depreciation & amortization: 13060.294117647058
Net tangible assets: 10354597.058823528
Owner earnings: -7698374.2647058815
Return on net tangible assets (%): -74.3474055144021
Buffett classification: The Gruesome
Stock price: 0.11764705882352941
Shares outstanding: 188697567
Book value: 10354597.058823528
P/B ratio: 2.1439476242862296
Market cap (USD): 22199713.76470588
Debt to equity: 0.0028404547795338416
Current ratio: 2.885966987530793
Quick ratio: 2.885966987530793
Interest coverage ratio: -554.3775698284418
Free cash flow (dilution-adjusted): -6665377.205882353
Buyback yield (%): 0
Retained earnings: -8414138.970588235
Receivables turnover: 0
Capitalized R&D asset: 193402.20588235292
ROCI (R&D-adjusted, %): -26.034165432869354
Rule of 40 score: 0
Financial ratios for ECU.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -30050
Operating income: -1442222.7272727273
Net income: -1453748.4848484849
Capital expenditures: 1064390.909090909
Operating cash flow: -1407699.2424242424
Depreciation & amortization: 30050
Net tangible assets: 11932115.909090908
Owner earnings: -2488089.3939393936
Return on net tangible assets (%): -20.852038422152386
Buffett classification: The Gruesome
Stock price: 0.13636363636363635
Shares outstanding: 188697567
Book value: 11932115.909090908
P/B ratio: 2.1564898133018016
Market cap (USD): 25731486.409090906
Debt to equity: 0.0027780259197341933
Current ratio: 9.038456830922131
Quick ratio: 9.038456830922131
Interest coverage ratio: -185.4948845366852
Free cash flow (dilution-adjusted): -2600387.121212121
Buyback yield (%): 0
Retained earnings: -10122861.363636363
Receivables turnover: 0
Capitalized R&D asset: 240385.53854723705
ROCI (R&D-adjusted, %): -11.760993136417081
Rosenberg metric: -0.08784649484653669
Rule of 40 score: 0
Financial ratios for ECU.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.18518518518518517
Shares outstanding: 188697567
Market cap (USD): 34943993.88888889
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0